Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Running, not enrolling · Phase 3 · Has a placebo group
Conditions studied: Leukemia
In brief
This study will compare the effects of Quizartinib versus placebo in combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute myeloid leukemia (AML).
Key facts
- Study ID
- NCT06578247
- Run by
- Daiichi Sankyo
- People needed
- 700
- Starts
- 2024-11-19
- Expected to finish
- 2030-06-26
- Last updated by the study team
- 2026-07-02
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic - Phoenix — Phoenix, Arizona, United States
- University of Arizona Cancer Center — Tucson, Arizona, United States
- David Geffen School of Medicine — Los Angeles, California, United States
- University of California Davis Health System — Sacramento, California, United States
- Ucsf Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States
- Stanford University School of Medicine- Parent — Stanford, California, United States
- Colorado Blood Cancer Institute — Denver, Colorado, United States
- Yale University — New Haven, Connecticut, United States
- Sibley Memorial Hospital — Washington D.C., District of Columbia, United States
- Mayo Clinic Hospital — Jacksonville, Florida, United States
- Florida Hospital Cancer Institute - Kissimmee — Kissimmee, Florida, United States
- Tampa General Hospital — Tampa, Florida, United States
- Moffitt Cancer Center — Tampa, Florida, United States
- Winship Cancer Institute of Emory University — Atlanta, Georgia, United States
- Augusta University — Augusta, Georgia, United States
- Robert H Lurie Comprehensive Cancer Center Northwestern University — Chicago, Illinois, United States
- University of Illinois Hospital & Health Sciences System — Chicago, Illinois, United States
- The University of Chicago Medical Center — Chicago, Illinois, United States
- University of Kentucky — Lexington, Kentucky, United States
- Ochsner Medical Center - New Orleans — New Orleans, Louisiana, United States
- Johns Hopkins Hospital — Baltimore, Maryland, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center Michigan Medicine — Ann Arbor, Michigan, United States
- University of Minnesota Medical School - Twin Cities Campus — Minneapolis, Minnesota, United States
- City of Hope Phoenix — Goodyear, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.